Original Research

Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints

Kuti JL, Wang Q, Chen H, Li H, Wang H, Nicolau DP

Infection and Drug Resistance 2018, 11:783-790

Published Date: 25 May 2018